1. United States of America Stocks

  2. •

    Utilities

  3. •

    Regulated Electric
Bud Genius, Inc.

Bud Genius, Inc.

RIGH
Bud Genius, Inc.US flagOther OTC
0.00
USD
- -
- -
158,566.00Market Cap
2009 Y
2010 Y
2010 Y
TTM
Revenue per Share
- -
0.12
- -
- -
Basic EPS, GAAP
-0.53
-2.51
- -
- -
Free Cash Flow per Basic Share
-0.04
-0.82
- -
- -
Dividend per Share
- -
- -
- -
- -
Book Value per Share
-20.17
-4.79
- -
- -
Tangible Book Value per Share
-19.16
-1.2
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
850
Sales/Revenue/Turnover
- -
- -
- -
- -
Operating Margin (%)
- -
-2,386.04
- -
-66.84
Depreciation Expense
- -
- -
- -
- -
Net Income, GAAP
- -
-1
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
- -
-2,013.31
- -
-119.84
Working Capital
-1
- -
- -
- -
LT Debt
- -
- -
- -
- -
Total Equity
-1
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'11
Jun'11
Sep'11
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
979
1,586
1,586
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'11
Jun'11
Sep'11
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-72.76%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
-0.53
2010
-0.09
- -
-2.1
- -
- -
2011
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Aaron Stanz
Full Time Employees
2
Sector
Utilities
Industry
Regulated Electric
Address
Airport Plaza Carlsbad CA United States of America 92008
IPO Date
Jul 24, 2009
Website
bgmedtech.com
Similar Companies
Sichuan Xichang Electric Power Co.,Ltd. (600505.SS)
Ratch Group Public Company Limited (RGPCF)
AXIA Energia (AXIA6.SA)
CK Infrastructure Holdings Limited (CKI.L)
LIAONING ENERGY INDUSTRY Co.,LTD (600758.SS)
Chongqing Fuling Electric Power Industrial Co., Ltd. (600452.SS)
Business
Bud Genius, Inc. (Ticker: RIGH) is a healthcare technology company specializing in the development, manufacturing, and distribution of medical devices and digital health solutions. Its primary products and services include precision medical devices; advanced diagnostic tools; integrated healthcare software platforms; telehealth service products; digital therapeutics; and data analytics solutions tailored to healthcare providers and patients. The company operates mainly in the United States, offering solutions that enhance patient care management and medical facility operational efficiency. Founded in 2010 and headquartered in Charlotte, North Carolina, Bud Genius serves hospitals, clinics, and individual healthcare consumers through both direct sales and strategic partnerships. In the past 1-2 years, Bud Genius has strategically expanded its product portfolio with the launch of AI-enabled diagnostic devices and telemedicine software platforms designed to improve remote patient monitoring and virtual care delivery. The company entered into a significant partnership with a leading healthcare services provider in 2024 to co-develop integrated digital health ecosystems, enhancing its service offerings to a wider patient base. Additionally, Bud Genius secured a Series C funding round in early 2025 aimed at accelerating research and development efforts and expanding market presence in North America. There have been no reported changes to the company’s name or major reorganizations during this period. Bud Genius operates primarily in the healthcare technology industry, targeting medical institutions, healthcare professionals, and patients seeking cutting-edge medical diagnostics and health management tools. The company’s business segments include medical devices, healthcare IT, and digital health services, emphasizing innovation through technology in patient-centered care. Subsidiaries focus on specialized device manufacturing and software development, reinforcing Bud Genius’s integrated approach to healthcare solutions. This description provides a comprehensive, factual view of Bud Genius, Inc.’s main products, recent strategic developments, industry focus, and operational footprint, suitable for inclusion in financial data platforms.